(TSM) Taiwan Semiconductor - Overview
Wafer, Chip, Foundry, Process, Logic
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.15% |
| Yield on Cost 5y | 3.12% |
| Yield CAGR 5y | 9.35% |
| Payout Consistency | 96.5% |
| Payout Ratio | 20.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 35.7% |
| Relative Tail Risk | -5.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.50 |
| Alpha | 56.73 |
| Character TTM | |
|---|---|
| Beta | 1.445 |
| Beta Downside | 1.493 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.87% |
| CAGR/Max DD | 1.53 |
Description: TSM Taiwan Semiconductor January 28, 2026
Taiwan Semiconductor Manufacturing Company Limited (TSM) is the world’s largest dedicated semiconductor foundry, offering end-to-end services from wafer fabrication (CMOS logic, mixed-signal, RF, embedded memory, etc.) to packaging, testing, mask making, and engineering support across a global customer base.
Its product portfolio underpins high-performance computing, smartphones, IoT, automotive electronics, and consumer devices, positioning TSM at the core of multiple high-growth tech ecosystems.
Key recent metrics (Q4 2025): revenue $24.5 bn (+12% YoY), fab utilization 92%, capex $9.2 bn (≈38% of revenue) focused on 3-nm and 2-nm node expansion, and R&D spend $3.1 bn (≈13% of revenue). The company holds roughly 55% market share in the advanced-node foundry segment, a lead that is reinforced by the accelerating demand for AI-accelerators and automotive-grade chips.
Macro drivers include sustained AI server growth (+30% YoY in Q4 2025), ongoing U.S.–China technology tensions prompting “friend-shoring” of semiconductor supply chains, and a tightening of global chip capacity that benefits TSM’s premium-price positioning.
For a deeper quantitative dive, the ValueRay platform provides granular analytics that can help you assess TSM’s risk-adjusted upside.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 1722.66b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA -0.10 > 1.0 |
| NWC/Revenue: 61.60% < 20% (prev 63.01%; Δ -1.41% < -1%) |
| CFO/TA 0.29 > 3% & CFO 2291.19b > Net Income 1722.66b |
| Net Debt (-1769.70b) to EBITDA (2896.13b): -0.61 < 3 |
| Current Ratio: 2.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (5.19b) vs 12m ago 0.01% < -2% |
| Gross Margin: 59.90% > 18% (prev 0.56%; Δ 5934 % > 0.5%) |
| Asset Turnover: 52.30% > 50% (prev 43.25%; Δ 9.05% > 0%) |
| Interest Coverage Ratio: 315.9 > 6 (EBITDA TTM 2896.13b / Interest Expense TTM 6.47b) |
Altman Z'' 8.07
| A: 0.30 (Total Current Assets 3806.38b - Total Current Liabilities 1453.91b) / Total Assets 7910.68b |
| B: 0.59 (Retained Earnings 4691.82b / Total Assets 7910.68b) |
| C: 0.28 (EBIT TTM 2043.09b / Avg Total Assets 7301.31b) |
| D: 2.20 (Book Value of Equity 5420.96b / Total Liabilities 2465.27b) |
| Altman-Z'' Score: 8.07 = AAA |
Beneish M -2.28
| DSRI: 0.78 (Receivables 281.00b/272.09b, Revenue 3818.94b/2894.31b) |
| GMI: 0.94 (GM 59.90% / 56.12%) |
| AQI: 2.40 (AQ_t 0.05 / AQ_t-1 0.02) |
| SGI: 1.32 (Revenue 3818.94b / 2894.31b) |
| TATA: -0.07 (NI 1722.66b - CFO 2291.19b) / TA 7910.68b) |
| Beneish M-Score: -2.28 (Cap -4..+1) = BBB |
What is the price of TSM shares?
Over the past week, the price has changed by +4.96%, over one month by +13.75%, over three months by +13.81% and over the past year by +71.06%.
Is TSM a buy, sell or hold?
- StrongBuy: 11
- Buy: 5
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TSM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 419.8 | 22.6% |
| Analysts Target Price | 419.8 | 22.6% |
| ValueRay Target Price | 491.2 | 43.5% |
TSM Fundamental Data Overview January 24, 2026
P/E Forward = 24.8756
P/S = 0.4458
P/B = 10.6863
P/EG = 1.2092
Revenue TTM = 3818.94b USD
EBIT TTM = 2043.09b USD
EBITDA TTM = 2896.13b USD
Long Term Debt = 918.23b USD (from longTermDebt, two quarters ago)
Short Term Debt = 136.54b USD (from shortTermDebt, last quarter)
Debt = 990.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1769.70b USD (from netDebt column, last quarter)
Enterprise Value = -371.69b USD (1697.91b + Debt 990.36b - CCE 3059.95b)
Interest Coverage Ratio = 315.9 (Ebit TTM 2043.09b / Interest Expense TTM 6.47b)
EV/FCF = -0.36x (Enterprise Value -371.69b / FCF TTM 1019.79b)
FCF Yield = -274.4% (FCF TTM 1019.79b / Enterprise Value -371.69b)
FCF Margin = 26.70% (FCF TTM 1019.79b / Revenue TTM 3818.94b)
Net Margin = 45.11% (Net Income TTM 1722.66b / Revenue TTM 3818.94b)
Gross Margin = 59.90% ((Revenue TTM 3818.94b - Cost of Revenue TTM 1531.48b) / Revenue TTM)
Gross Margin QoQ = 62.33% (prev 59.45%)
Tobins Q-Ratio = -0.05 (set to none) (Enterprise Value -371.69b / Total Assets 7910.68b)
Interest Expense / Debt = 0.01% (Interest Expense 98.8m / Debt 990.36b)
Taxrate = 14.68% (87.77b / 597.96b)
NOPAT = 1743.20b (EBIT 2043.09b * (1 - 14.68%))
Current Ratio = 2.62 (Total Current Assets 3806.38b / Total Current Liabilities 1453.91b)
Debt / Equity = 0.18 (Debt 990.36b / totalStockholderEquity, last quarter 5404.33b)
Debt / EBITDA = -0.61 (Net Debt -1769.70b / EBITDA 2896.13b)
Debt / FCF = -1.74 (Net Debt -1769.70b / FCF TTM 1019.79b)
Total Stockholder Equity = 4886.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 23.59% (Net Income 1722.66b / Total Assets 7910.68b)
RoE = 35.25% (Net Income TTM 1722.66b / Total Stockholder Equity 4886.97b)
RoCE = 35.19% (EBIT 2043.09b / Capital Employed (Equity 4886.97b + L.T.Debt 918.23b))
RoIC = 34.64% (NOPAT 1743.20b / Invested Capital 5032.44b)
WACC = 7.10% (E(1697.91b)/V(2688.26b) * Re(11.24%) + D(990.36b)/V(2688.26b) * Rd(0.01%) * (1-Tc(0.15)))
Discount Rate = 11.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.00%
[DCF Debug] Terminal Value 83.69% ; FCFF base≈959.61b ; Y1≈1130.53b ; Y5≈1731.63b
Fair Price DCF = 7273 (EV 35950.81b - Net Debt -1769.70b = Equity 37720.51b / Shares 5.19b; r=7.10% [WACC]; 5y FCF grow 18.98% → 2.90% )
EPS Correlation: 62.72 | EPS CAGR: 24.27% | SUE: 4.0 | # QB: 4
Revenue Correlation: 90.01 | Revenue CAGR: 22.65% | SUE: 0.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=3.29 | Chg30d=+0.538 | Revisions Net=+4 | Analysts=4
EPS current Year (2026-12-31): EPS=14.31 | Chg30d=+1.589 | Revisions Net=+7 | Growth EPS=+34.4% | Growth Revenue=+30.8%
EPS next Year (2027-12-31): EPS=18.00 | Chg30d=+2.397 | Revisions Net=+5 | Growth EPS=+25.8% | Growth Revenue=+20.9%